News Aprogen Biologics Inc.

Equities

A003060

KR7003060001

End-of-day quote Korea S.E. Other stock markets 23:00:00 01/07/2024 BST			5-day change	1st Jan Change
1,010 ^KRW	-0.10%		-0.49%	-65.17%

03-13	Aprogen Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Aprogen Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-13	CI
Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Aprogen Biologics Inc.(KOSE:A003060) dropped from S&P Global BMI Index	18/09/23	CI
Aprogen Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Aprogen Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Aprogen Biologics Inc. announced that it has received KRW 20 billion in funding from Aprogen, Inc.	23/04/23	CI
Aprogen Biologics Inc. announced that it expects to receive KRW 20 billion in funding from Aprogen, Inc.	20/04/23	CI
Aprogen Biologics Inc. announced that it has received KRW 40 billion in funding	13/04/23	CI
Aprogen Biologics Inc. announced that it expects to receive KRW 40 billion in funding	12/04/23	CI
Aprogen Biologics Inc. announced that it has received KRW 40.0000005 billion in funding from Aprogen Medicines Inc.	11/04/23	CI
Aprogen pharmaceuticals,Inc. completed the acquisition of Aprogen Biologics Inc. from Aprogen, Inc.	30/12/22	CI
Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/11/22	CI
Aprogen Pharmaceuticals to Raise $35.1 Million Through Stock Issuance	04/10/22	MT
Aprogen pharmaceuticals,Inc. agreed to acquire Aprogen Biologics Inc. from Aprogen, Inc.	03/10/22	CI
Aprogen Biologics Inc. announced that it expects to receive KRW 50 billion in funding from Aprogen Medicines Inc.	03/10/22	CI
Aprogen pharmaceuticals,Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22	CI
Aprogen pharmaceuticals,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22	CI
Aprogen pharmaceuticals,Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	14/03/22	CI
Aprogen pharmaceuticals,Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	11/11/21	CI
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc.	15/09/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Aprogen Biologics Inc.

Equities

A003060

KR7003060001

Summary

Filters